Biotech and biopharma companies have battled with a drought of private investmen...
Pfizer has divested its residual shareholding in Haleon, representing 7.3% of th...
OBT has entered a multi-year partnership with Roche to discover antibody-based t...
Among the 13 CAR-T therapeutics that have received regulatory approval are Gilea...
The US Patent and Trademark Office (USPTO) has allowed two new patents for Remed...
J&J has received US FDA approval for Tremfya (guselkumab), to treat moderately t...
Sanofi’s move for Dren Bio’s clinical asset boosts its immunology-focused strate...
Servier and Black Diamond Therapeutics have signed a licencing agreement for tar...
A key trend seen in 2024 and recent years is the simplification of basket sizes,...
Investigators said that the OLE study showed Roche’s gantenerumab dropped the ri...
Health Canada has granted approval for Biogen’s Skyclarys to treat Friedreich’s ...
The use of AI in drug discovery and development has been recognised, explored, a...
AstraZeneca has entered an exclusive licence agreement with Alteogen involving t...
Experts at the 2025 Clinical Trial Supply New England conference will discuss st...
The two simultaneous Incyte trials in HS saw more than 40% of patients on povorc...
